Works by Brandt, Simon

Results: 92
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration study.

    Published in:
    Drug Testing & Analysis, 2024, v. 16, n. 9, p. 1002, doi. 10.1002/dta.3622
    By:
    • Angerer, Verena;
    • Schmid, Yasmin;
    • Franz, Florian;
    • Gnann, Heike;
    • Speer, Jan Manuel;
    • Gnann, Anke;
    • Helmecke, Stephan;
    • Buchwald, Armin;
    • Brandt, Simon D.;
    • Passie, Torsten;
    • Liechti, Matthias E.;
    • Auwärter, Volker
    Publication type:
    Article
    12
    13
    14

    In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin‐8‐yl 4‐methyl‐3‐(morpholine‐4‐sulfonyl)benzoate [QMMSB]) and (quinolin‐8‐yl 4‐methyl‐3‐((propan‐2‐yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testing

    Published in:
    Drug Testing & Analysis, 2023, v. 15, n. 2, p. 181, doi. 10.1002/dta.3385
    By:
    • Richter, Matthias J.;
    • Wagmann, Lea;
    • Kavanagh, Pierce V.;
    • Brandt, Simon D.;
    • Meyer, Markus R.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4‐methylphenmetrazine (4‐MPM), with differentiation from its ortho‐ and meta‐ positional isomers.

    Published in:
    Drug Testing & Analysis, 2018, v. 10, n. 9, p. 1404, doi. 10.1002/dta.2396
    By:
    • McLaughlin, Gavin;
    • Baumann, Michael H.;
    • Kavanagh, Pierce V.;
    • Morris, Noreen;
    • Power, John D.;
    • Dowling, Geraldine;
    • Twamley, Brendan;
    • O'Brien, John;
    • Hessman, Gary;
    • Westphal, Folker;
    • Walther, Donna;
    • Brandt, Simon D.
    Publication type:
    Article
    29

    An approach to shortening the timeframe between the emergence of new compounds on the drugs market and the availability of reference standards: The microscale syntheses of nitrazolam and clonazolam for use as reference materials, utilizing polymer‐supported reagents

    Published in:
    Drug Testing & Analysis, 2018, v. 10, n. 7, p. 1198, doi. 10.1002/dta.2383
    By:
    • Dowling, Geraldine;
    • Kavanagh, Pierce V.;
    • Eckhardt, Hans‐Georg;
    • Twamley, Brendan;
    • Hessman, Gary;
    • McLaughlin, Gavin;
    • O'Brien, John;
    • Brandt, Simon D.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Analysis of six 'neuro-enhancing' phenidate analogs.

    Published in:
    Drug Testing & Analysis, 2017, v. 9, n. 3, p. 423, doi. 10.1002/dta.2161
    By:
    • Klare, Helge;
    • Neudörfl, Jörg M.;
    • Brandt, Simon D.;
    • Mischler, Elisabeth;
    • Meier ‐ Giebing, Sigrid;
    • Deluweit, Kathrin;
    • Westphal, Folker;
    • Laussmann, Tim
    Publication type:
    Article
    40

    Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)- threo and (±)- erythro diastereomers.

    Published in:
    Drug Testing & Analysis, 2017, v. 9, n. 3, p. 347, doi. 10.1002/dta.2167
    By:
    • McLaughlin, Gavin;
    • Morris, Noreen;
    • Kavanagh, Pierce V.;
    • Power, John D.;
    • Dowling, Geraldine;
    • Twamley, Brendan;
    • O'Brien, John;
    • Hessman, Gary;
    • Murphy, Brian;
    • Walther, Donna;
    • Partilla, John S.;
    • Baumann, Michael H.;
    • Brandt, Simon D.
    Publication type:
    Article
    41
    42

    Outsmarted by nootropics?

    Published in:
    Drug Testing & Analysis, 2017, v. 9, n. 3, p. 518, doi. 10.1002/dta.2142
    By:
    • Dowling, Geraldine;
    • Kavanagh, Pierce V.;
    • Talbot, Brian;
    • O’Brien, John;
    • Hessman, Gary;
    • McLaughlin, Gavin;
    • Twamley, Brendan;
    • Brandt, Simon D.
    Publication type:
    Article
    43
    44
    45

    Return of the lysergamides. Part II: Analytical and behavioural characterization of N<sup>6</sup>-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2' S,4' S)-lysergic acid 2,4-dimethylazetidide (LSZ).

    Published in:
    Drug Testing & Analysis, 2017, v. 9, n. 1, p. 38, doi. 10.1002/dta.1985
    By:
    • Brandt, Simon D.;
    • Kavanagh, Pierce V.;
    • Westphal, Folker;
    • Elliott, Simon P.;
    • Wallach, Jason;
    • Colestock, Tristan;
    • Burrow, Timothy E.;
    • Chapman, Stephen J.;
    • Stratford, Alexander;
    • Nichols, David E.;
    • Halberstadt, Adam L.
    Publication type:
    Article
    46
    47
    48
    49
    50